Application of modified laparoscopic radical hysterectomy in the treatment of early cervical cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026306

Enrollment

Unknown

Registered

2019-09-29

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Experimental group:Modified laparoscopic radical hysterectomy

Control group:Open surgery

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-65 years; 2) Stage IA1 (LVSI+), IA2, IB1, IB2 and IIA1 (2018 FIGO staging) early cervical cancer; 3) Pathological types: Squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma; 4) All signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Distant metastasis was found before surgery; 2) The size of uterus exceeds 3 months; 3) Pregnant women; 4) Preoperative neoadjuvant chemotherapy or radiotherapy; 5) Life expectancy less than 6 months; 6) Fail to receive follow-up visits on schedule; 7) Patients with systemic serious basic diseases, immune diseases, mental diseases or other malignant tumors.

Design outcomes

Primary

Measure	Time frame
5-year disease-free survival (DFS);oral survival;5-year recurrence rate;	—

Secondary

Measure	Time frame
Perioperative complications;Postoperative life quality;	—

Countries

China

Contacts

Public ContactLi Xuqing

The First Affiliated Hospital of Anhui Medical University

117511687@qq.com+86 13966720150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026